Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-12

FDA Approved: PRASUGREL — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Mylan Pharmaceuticals' original application for a generic prasugrel product, intended to reduce thrombotic events in adults with acute coronary syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRASUGREL (prasugrel)

Snippet

ORIG AP for PRASUGREL (PRASUGREL)